Authorized Generic

Quote






Some insight to why-

“There’s a lot of parts of the system that just automatically switch to generics, whatever the source, So even if the authorized generic isn’t much cheaper than the brand, “it’s almost like a no-brainer” to roll one out”
 












anonymous said:
Some insight to why-

“There’s a lot of parts of the system that just automatically switch to generics, whatever the source, So even if the authorized generic isn’t much cheaper than the brand, “it’s almost like a no-brainer” to roll one out”
Click to expand...

the net price for the AG is significantly higher than any of the branded agents. Few if any plans or PBM’s will add it to their formulary. It makes no financial sense.
 












anonymous said:
So are you saying you know what AZs strategy is? If you don’t, then you really don’t know much about this.
Click to expand...

their price is 35% less than Fx or JD. That discount is significantly less than what AZ and other SGLT2i manufacturers are offering in terms of rebates.

Prasco is not going to discount it any further.

there are your facts. Oh, you’re also a douchebag:
 






anonymous said:
their price is 35% less than Fx or JD. That discount is significantly less than what AZ and other SGLT2i manufacturers are offering in terms of rebates.

Prasco is not going to discount it any further.

there are your facts. Oh, you’re also a douchebag:
Click to expand...

So why would they even do it if your facts are correct?
 






anonymous said:
their price is 35% less than Fx or JD. That discount is significantly less than what AZ and other SGLT2i manufacturers are offering in terms of rebates.

Prasco is not going to discount it any further.

there are your facts. Oh, you’re also a douchebag:[/QUOTE

Ok, assume you are correct. What happens in 2025? When does BI begin preparing for 2025? Would you say we have until Q3?
Does not matter how you look at it, our time here is limited (I bet 8-11 more months). It is to be expected in our industry.
Click to expand...
 


































































anonymous said:
that’s a lie. CVS Caremark is not covering the AG.
Click to expand...
Most plans have an auto update built in and when a new drug comes to market it defaults to covered until the plan corrects it. Everything has to go through a P&T process before formulary additions can be made. This is causing confusion and misinformation. If you were on the call yesterday, it was explained that formulary decision have not been made. Most plans and hospitals still have not reviewed it. The branded SGLT2i’s still have some time in 2024. The question is ‘how much time’? Next year will be game over.
 






anonymous said:
Most plans have an auto update built in and when a new drug comes to market it defaults to covered until the plan corrects it. Everything has to go through a P&T process before formulary additions can be made. This is causing confusion and misinformation. If you were on the call yesterday, it was explained that formulary decision have not been made. Most plans and hospitals still have not reviewed it. The branded SGLT2i’s still have some time in 2024. The question is ‘how much time’? Next year will be game over.
Click to expand...


Spoken like someone who actually knows what they’re doing. Relatively accurate, except most don’t auto cover it. Majority will have it non covered until they do a full P&T review. That could take a few months and with the lack of financial savings or rebate guarantees, the likelihood of the AG being covered (or even preferred) are highly unlikely. Plans would be giving up far too much in guaranteed rebates if they added the AG.
 






Top Bottom
Back
Quote